Website Header with Language Selector and Dropdowns
Image

Bacitracin EP Impurity H


Catalog Number: CL-BCTR-009
CAS No.: 144572-55-4
Mol.F: C65H96N16O17S
Mol.W: 1405.6
Inv. Status: Custom Synthesis

Chemical Name: (4R)-5-(((2S)-1-(((3S,6R,9S,12R,15S,21S)-9-((1H-imidazol-5-yl)methyl)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-((S)-sec-butyl)-6-(carboxymethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-21-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-4-(2-((S)-5-methyl-1-(2-((S)-2-methylbutanoyl)thiazol-4-yl)-1,2-dioxohexan-3-yl)hydrazinyl)-5-oxopentanoic acid.

Country of Origin: India

Product Category: Bacitracin Impurities


Bacitracin EP Impurity H is identified by CAS No. 144572-55-4 and is chemically known as (4R)-5-(((2S)-1-(((3S,6R,9S,12R,15S,21S)-9-((1H-imidazol-5-yl)methyl)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-((S)-sec-butyl)-6-(carboxymethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-21-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-4-(2-((S)-5-methyl-1-(2-((S)-2-methylbutanoyl)thiazol-4-yl)-1,2-dioxohexan-3-yl)hydrazinyl)-5-oxopentanoic acid.

Bacitracin EP Impurity H is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Bacitracin.

Page Keywords: Buy Bacitracin EP Impurity H | Purchase Bacitracin EP Impurity H | Bacitracin EP Impurity H suppliers | Bacitracin EP Impurity H manufacturers | Bacitracin EP Impurity H price | Bacitracin EP Impurity H Importer | Bacitracin EP Impurity H Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-BCTR-001
CAS No: 1405-87-4
Mol Wt: 1422.7
Mol F: C66H103N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-020
CAS No: 22601-59-8
Mol Wt: 1422.7
Mol F: C66H103N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-021
CAS No: 57762-79-5
Mol Wt: 1408.7
Mol F: C65H101N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-022
CAS No: 57762-78-4
Mol Wt: 1408.7
Mol F: C65H101N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-023
CAS No: 149146-32-7
Mol Wt: 1408.7
Mol F: C65H101N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-002
CAS No: NA
Mol Wt: 1394.7
Mol F: C64H99N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-003
CAS No: NA
Mol Wt: 1394.7
Mol F: C64H99N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-004
CAS No: NA
Mol Wt: 1394.7
Mol F: C64H99N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-005
CAS No: NA
Mol Wt: 1380.6
Mol F: C63H97N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-006
CAS No: 22601-63-4
Mol Wt: 1419.7
Mol F: C66H98N16O17S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-007
CAS No: 167289-64-7
Mol Wt: 1405.6
Mol F: C65H96N16O17S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-008
CAS No: 144572-54-3
Mol Wt: 1405.6
Mol F: C65H96N16O17S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-010
CAS No: NA
Mol Wt: 1391.6
Mol F: C64H94N16O17S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-011
CAS No: NA
Mol Wt: 1391.6
Mol F: C64H94N16O17S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-012
CAS No: 144572-52-1
Mol Wt: 1391.6
Mol F: C64H94N16O17S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-013
CAS No: NA
Mol Wt: 1422.7
Mol F: C66H103N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-014
CAS No: NA
Mol Wt: 1420.7
Mol F: C66H101N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-015
CAS No: NA
Mol Wt: 1422.7
Mol F: C66H103N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-016
CAS No: NA
Mol Wt: 1408.7
Mol F: C65H101N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-017
CAS No: NA
Mol Wt: 1422.7
Mol F: C66H103N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-018
CAS No: NA
Mol Wt: 1434.7
Mol F: C67H103N17O16S
Inv. Status: Custom Synthesis
CAT No: CL-BCTR-019
CAS No: 1405-89-6
Mol Wt: 1420.7 : 65.4
Mol F: C66H101N17O16S : Zn
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.